Does Medicham V have positive grading EV?

Based on current pricing, our model estimates a negative grading EV of $1.70 for Medicham V — grading costs currently exceed the estimated PSA-10 premium. This is a model estimate based on historical data, not investment advice.

What is the estimated grading EV for Medicham V?

Our model estimates approximately 4% return after grading costs, based on historical grade distributions and recent sold comps. Raw price: $19.85, estimated grading cost: ~$22.00, estimated EV: $1.70. Estimates are informational, not investment advice; trading cards are not securities.

Should You Grade Medicham V?

Evolving Skies · #186

Expected-value figures are estimates based on historical grade distributions and market prices. Not a recommendation. Grading outcomes and market prices are not guaranteed. Methodology · Full disclaimer

Estimated grading EV negative

Current grading costs exceed model estimate of PSA 10 premium

Expected Value

Raw price$19.85

Grading cost~$22.00

Blended EV$21.55

Estimated profit$1.70

Estimated return4%

Break-even sell price$-8.24

Profit by Grade

PSA 8 $15.97 $-25.88 (-62%)

PSA 9 $25.61 $-16.24 (-39%)